| 000 | 01314 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512202800.0 | ||
| 264 | 0 | _c19830407 | |
| 008 | 198304s 0 0 eng d | ||
| 022 | _a0271-9142 | ||
| 024 | 7 |
_a10.1007/BF00919137 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerrill, J E | |
| 245 | 0 | 0 |
_aNatural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cJan 1983 |
||
| 300 |
_a42-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAlprostadil |
| 650 | 0 | 4 |
_aAntibody-Dependent Cell Cytotoxicity _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInterferon Type I _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 |
_aProstaglandins E _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Fc _xdrug effects |
| 650 | 0 | 4 | _aReceptors, IgG |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 3 _gno. 1 _gp. 42-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00919137 _zAvailable from publisher's website |
| 999 |
_c6219122 _d6219122 |
||